The pay-it-forward testing strategy is emerging as a powerful tool to bridge significant healthcare gaps. Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain critical global health burdens. This is especially true in low- and middle-income countries where resources are often limited. Notably, international migrants residing in urban centers often face substantial barriers to routine screening. Consequently, researchers in China launched a cluster randomized controlled trial to address this challenge. The project utilizes social innovation to foster mutual aid within migrant communities. Ultimately, this approach aims to increase the uptake of life-saving medical tests for vulnerable groups.

How the Pay-it-forward Testing Strategy Enhances Screening

The core of this intervention relies on the concept of upstream reciprocity and community support. Specifically, the pay-it-forward testing strategy provides participants with free screening that previous participants donated. During the trial, the intervention group watches a short educational video about viral hepatitis risks. Furthermore, they receive printed materials detailing how testing can prevent long-term liver damage. After receiving their free tests, participants have the voluntary opportunity to donate to support a future participant. In contrast, the control group pays out-of-pocket for standard medical services at the hospital. Because financial cost is a major deterrent, this model effectively removes immediate economic hurdles.

Implementation of the protocol began in late 2024 in Guangzhou, China. Early baseline findings indicate a high representation of male participants, primarily from African nations. Many of these individuals reside in the region for business purposes. Although some earn stable incomes, a significant portion still lacks regular access to viral hepatitis screening. As a result, the study will measure the proportion of participants who complete both HBV and HCV tests. Moreover, the data analysis will account for clustering effects to ensure the accuracy of the intervention’s impact.

Impact of Pay-it-forward Testing Strategy on Public Health

This study is innovative because it targets an understudied and often marginalized population. The pay-it-forward testing strategy does more than just lower costs; it builds a sense of community responsibility. Previous studies in China have shown that this model works effectively for sexually transmitted infections. Consequently, applying it to hepatitis could redefine outreach for chronic viral infections. Healthcare providers in India can also look at this model to address screening gaps in urban migrant populations. Finally, the findings will provide evidence for future public health policies and more sustainable screening programs.

Frequently Asked Questions

What is the pay-it-forward testing strategy?

It is a social innovation model where an individual receives a health service for free, which was funded by a previous participant. The recipient is then invited to donate to support the next person.

Why is this strategy effective for migrant populations?

It overcomes financial barriers and reduces stigma by framing medical testing as a community-supported act of reciprocity rather than just an individual medical requirement.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Xiong M et al. Evaluating Pay-It-Forward Strategy to Promote Hepatitis B Virus and Hepatitis C Virus Testing Among International Migrants From Low- and Middle-Income Countries in China: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2026 May 21. doi: 10.2196/87165. PMID: 42166794.

Tucker JD et al. Pay-it-forward to promote HIV and Chlamydia testing among men who have sex with men in China: a cluster randomized trial. Lancet Infect Dis. 2017;17(12):1234-1241.

World Health Organization. Global Hepatitis Report 2024: Action for access in low- and middle-income countries. Geneva: WHO; 2024.